BioSurplus, America’s preeminent buyer and reseller of preowned lab equipment, has appointed Shelley Amster to its Board of Directors, bringing on a well-connected leader with extensive experience in the life science industry.

“Shelley will be an excellent addition to our board,” said Bill VanDeWeghe, president and CEO of BioSurplus. “Having worked with major trade organizations and companies of all sizes, she provides extensive insight regarding the needs customers have and how they can best be served. We look forward to having her guidance and leadership as we continue to grow.”

Shelley Amster has worked in the life science and health industries for more than 30 years, beginning with her research on infertility. She currently serves as founder and principal at ShelleyCO, a life science business development consulting firm, and also serves as a business development and marketing advisor for both CATALENT (previously Juniper Pharma Services) and DxNow, Inc. Shelley is an advisory board member for Mansfield Bio-Incubator, a non-profit organization that facilitates growth for next generation biotech companies. She also serves on the advisory board for the Health and STEM Pathway’s Center Program at Middlesex Community College. She holds a Bachelor of Science degree in medical technology from the University of New England.


Click here to view the complete release on PR Newswire!